Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding. - Grimaldi, D; Canoui-Poitrine, F; Croisille, L (Ann Hematol, 2014)
et al.